Sanofi
Tracked across 22 events · 175 articles · First seen Dec 05, 2025 · Last active Jun 09, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Tech
Impact: Sanofi announced positive Phase 2 clinical trial results for its drug lunsekimig in respiratory diseases, which could lead to new treatment options and future revenue streams.
Apr 07, 2026 · 6 articles
Business
Impact: Sanofi, in collaboration with Regeneron Pharmaceuticals, developed Dupixent and received International — European Commission approval for its use in treating chronic spontaneous urticaria in young children, which is expected to boost its market position and revenue.
Apr 13, 2026 · 8 articles
Business
The United States — Food and Drug Administration has granted priority review to Sanofi's new drug application for venglustat, an investigational oral glucosylceramide synthase inhibitor, for the treatment of type 3 Gaucher disease (GD3). This…
Impact: Sanofi has received priority review for its drug venglustat, which could significantly expand its portfolio in lysosomal storage diseases and provide a new revenue stream if approved.
May 28, 2026 · 6 articles
Business
Sanofi>>>, a leading biopharmaceutical company, announced at Snowflake Inc. Summit 26 its adoption of Snowflake Inc.>>>'s AI Data Cloud and Elementum>>>'s AI solutions to transform its operations. This initiative aims to accelerate drug development, enhance…
Impact: Sanofi is adopting Snowflake Inc.'s AI Data Cloud and Elementum's AI solutions to accelerate drug development, improve sales operations, and become an AI-powered biopharma company. This move is expected to enhance its operational efficiency and innovation capabilities.
Jun 02, 2026 · 6 articles
Business
Sanofi has launched its 2026 global employee shareholder plan, Action 2026, which will open on June 9, 2026, to approximately 75,000 employees across 52 countries. This marks the 12th year of the program, demonstrating Sanofi's…
Impact: Sanofi launched its 2026 global employee stock purchase plan, Action 2026, to involve employees in the company's growth and results. This initiative aims to strengthen employee commitment and ownership in the company.
Jun 04, 2026 · 8 articles
Domestic
Impact: Sanofi is a major insulin maker that has moved to cut the cost of insulin and offers a savings program for people without health insurance.
Apr 02, 2026 · 6 articles
Regulatory
Altor BioScience's Board of Directors approved a financing plan backed by the Canada — Canada Growth Fund, securing KRW 300 billion (approximately USD 230 million) in long-term, low-interest financing. This decision follows the South Korea…
Impact: Sanofi is co-developing the GBP410 pneumococcal vaccine candidate with Altor BioScience. The financing secured by Altor BioScience will indirectly support the joint development efforts.
May 29, 2026 · 6 articles
Domestic
Impact: Sanofi, a hepatitis B vaccine maker, defended its products as safe, and its U.S.-listed shares ended up 1.3%.
Dec 05, 2025 · 7 articles
Tech
Impact: Sanofi is a sponsor of World Hemophilia Day 2026, supporting the World Federation of Hemophilia's efforts.
Apr 17, 2026 · 6 articles
Business
Cursor, a leading multi-model AI coding platform, announced its expansion into the EMEA region, establishing dedicated teams and opening a United Kingdom — London headquarters. This strategic move is a response to tripling revenue in…
Impact: Sanofi is mentioned as a customer of Cursor in the EMEA region, indicating its adoption of Cursor's AI coding platform.
Jun 09, 2026 · 8 articles
Regulatory
Impact: Sanofi is mentioned as a collaborator with Innate Pharma in immuno-oncology.
Apr 02, 2026 · 7 articles
Business
Impact: Sanofi is mentioned as a collaborator with Innate Pharma, indicating existing partnerships in immuno-oncology.
Apr 08, 2026 · 6 articles
Business
Impact: Ingrid Müller held senior international leadership roles at Sanofi prior to joining Evotec.
Apr 15, 2026 · 7 articles
Business
Impact: Dieter Weinand has led business operations for companies including Sanofi.
Apr 07, 2026 · 9 articles
Regulatory
Impact: Sanofi is mentioned as a biopharmaceutical company with whom Innate Pharma has established collaborations.
Apr 13, 2026 · 6 articles
100
Sanofi launched planSanofi launches 2026...
100
United States — Food and Drug Administration granted priority review SanofiSanofi's Venglustat Gets...
95
Snowflake Inc. announced partnership SanofiSanofi Adopts Snowflake AI...
90
Sanofi decided dividend distributionSanofi launches 2026...
90
Sanofi established new blueprintSanofi Adopts Snowflake AI...
85
Sanofi launched Concierge for FieldSanofi Adopts Snowflake AI...
80
Snowflake Inc. provided AI Data Cloud SanofiSanofi Adopts Snowflake AI...
70
Sanofi unified data Snowflake Inc.Sanofi Adopts Snowflake AI...
70
Sanofi requested admission Euronext ParisSanofi launches 2026...
NEWSDESK
Track Sanofi live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard